BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20363273)

  • 1. Association between matrix metalloproteinase 9 promoter polymorphisms and Behçet's disease.
    Lee YJ; Kang SW; Baek HJ; Choi HJ; Bae YD; Kang EH; Lee EY; Lee EB; Song YW
    Hum Immunol; 2010 Jul; 71(7):717-22. PubMed ID: 20363273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase-2, -9, -12, and tissue inhibitor of metalloproteinase 2 gene polymorphisms and cutaneous expressions in patients with Behçet's disease.
    Park KS; Min Y; Park SR; Kim EH; Lee DJ; Bang D; Lee ES
    Tissue Antigens; 2012 May; 79(5):333-9. PubMed ID: 22428754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of MMP-9 gene polymorphisms with Behçet's disease risk.
    Naouali A; Kaabachi W; Tizaoui K; Amor AB; Hamzaoui A; Hamzaoui K
    Immunol Lett; 2015 Mar; 164(1):18-24. PubMed ID: 25639450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-18 promoter polymorphisms in patients with Behçet's disease.
    Lee YJ; Kang SW; Park JJ; Bae YD; Lee EY; Lee EB; Song YW
    Hum Immunol; 2006 Oct; 67(10):812-8. PubMed ID: 17055358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of HYPA haplotype in the mannose-binding lectin gene-2 with Behçet's disease.
    Park KS; Min K; Nam JH; Bang D; Lee ES; Lee S
    Tissue Antigens; 2005 Mar; 65(3):260-5. PubMed ID: 15730518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix Metalloproteinase-9 rs17576 Gene Polymorphism and Behçet's Disease: Is There an Association?
    Kamal A; Elgengehy FT; Abd Elaziz MM; Gamal SM; Sobhy N; Medhat A; El Dakrony AHM
    Immunol Invest; 2017 Jul; 46(5):460-468. PubMed ID: 28388268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of Promoter Region of TNF-α Gene in Iranian Azeri Turkish Patients with Behçet's Disease.
    Abdolmohammadi R; Bonyadi M
    J Korean Med Sci; 2017 Jan; 32(1):33-37. PubMed ID: 27914129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT4 polymorphism in a Chinese Han population with Vogt-Koyanagi-Harada syndrome and Behçet's disease.
    Hu K; Yang P; Jiang Z; Hou S; Du L; Li F
    Hum Immunol; 2010 Jul; 71(7):723-6. PubMed ID: 20438790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-18 gene polymorphisms in aphthous stomatitis vs. Behçet's disease in a cohort of Egyptian patients.
    Hazzaa HH; Rashwan WA; Attia EA
    J Oral Pathol Med; 2014 Nov; 43(10):746-53. PubMed ID: 24935632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-9 promoter polymorphisms in Korean patients with systemic lupus erythematosus.
    Lee YJ; Woo M; Nam JH; Baek J; Im CH; Lee EY; Lee EB; Park KS; Song YW
    Hum Immunol; 2008 Jun; 69(6):374-9. PubMed ID: 18571010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with diabetic nephropathy.
    Maeda S; Haneda M; Guo B; Koya D; Hayashi K; Sugimoto T; Isshiki K; Yasuda H; Kashiwagi A; Kikkawa R
    Kidney Int; 2001 Oct; 60(4):1428-34. PubMed ID: 11576356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of the NOS3 gene in Tunisian patients with Behçet's disease.
    Kallel A; Sbaï MH; Houman MH; Sediri Y; Ouertani D; Smiti Khanfir M; Ben Ghorbel I; Jemaa R; Kaabachi N
    Int J Immunogenet; 2015 Apr; 42(2):87-92. PubMed ID: 25639851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SLC11A1 gene polymorphisms in Korean patients with Behçet's disease.
    Kim SK; Jang WC; Park SB; Park DY; Bang KT; Lee SS; Jun JB; Yoo DH; Chang HK
    Scand J Rheumatol; 2006; 35(5):398-401. PubMed ID: 17062442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single nucleotide polymorphisms in IL-10-mediated signalling pathways in Korean patients with Behçet's disease.
    Kang EH; Choi JY; Lee YJ; Lee EY; Lee EB; Song YW
    Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S27-32. PubMed ID: 24428981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of TNFA promoter region haplotype in Behçet's Disease.
    Park K; Kim N; Nam J; Bang D; Lee ES
    J Korean Med Sci; 2006 Aug; 21(4):596-601. PubMed ID: 16891799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
    Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between polymorphisms of FCRL3, a non-HLA gene, and Behçet's disease in a Chinese population with ophthalmic manifestations.
    Li K; Zhao M; Hou S; Du L; Kijlstra A; Yang P
    Mol Vis; 2008; 14():2136-42. PubMed ID: 19050767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTLA4 gene polymorphisms and soluble CTLA4 protein in Behcet's disease.
    Park KS; Baek JA; Do JE; Bang D; Lee ES
    Tissue Antigens; 2009 Sep; 74(3):222-7. PubMed ID: 19563524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of macrophage migration inhibitory factor gene polymorphisms with Behçet's disease in a Han Chinese population.
    Zheng X; Wang D; Hou S; Zhang C; Lei B; Xiao X; Kijlstra A; Yang P
    Ophthalmology; 2012 Dec; 119(12):2514-8. PubMed ID: 22939113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between IL17A, IL23R, and STAT4 polymorphisms confer susceptibility to intestinal Behcet's disease in Korean population.
    Kim ES; Kim SW; Moon CM; Park JJ; Kim TI; Kim WH; Cheon JH
    Life Sci; 2012 May; 90(19-20):740-6. PubMed ID: 22483685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.